Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Rockwell Medical's ebitda for the twelve months ending Jun 30, 2026 was -$2.43M, down 371.2% year over year. For fiscal 2025 it was -$2.50M, down 189.6% from the year before. The highest annual figure on record is $2.79M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.50M | -189.6% |
| FY2024 | Dec 31, 2024 | $2.79M | – |
| FY2023 | Dec 31, 2023 | -$5.23M | – |
| FY2022 | Dec 31, 2022 | -$16.20M | – |
| FY2021 | Dec 31, 2021 | -$29.67M | – |
| FY2020 | Dec 31, 2020 | -$27.59M | – |
| FY2019 | Dec 31, 2019 | -$33.74M | – |
| FY2018 | Dec 31, 2018 | -$31.79M | – |
| FY2017 | Dec 31, 2017 | -$25.41M | – |
| FY2016 | Dec 31, 2016 | -$19.45M | – |
| FY2015 | Dec 31, 2015 | -$14.28M | – |
| FY2014 | Dec 31, 2014 | -$16.56M | – |
| FY2013 | Dec 31, 2013 | -$46.05M | – |
| FY2012 | Dec 31, 2012 | -$53.17M | – |
| FY2011 | Dec 31, 2011 | -$20.51M | – |
| FY2010 | Dec 31, 2010 | -$1.48M | – |
| FY2009 | Dec 31, 2009 | -$4.25M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$569.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$969.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $148.00K | +516.7% |
| Q3 FY2025 | Sep 30, 2025 | -$1.04M | -142.0% |
| Q2 FY2025 | Jun 30, 2025 | -$786.00K | -173.9% |
| Q1 FY2025 | Mar 31, 2025 | -$821.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $24.00K | +700.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.48M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.06M | – |
| Q1 FY2024 | Mar 31, 2024 | -$779.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $3.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.17M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.79M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.27M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.34M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.23M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.82M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.98M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.40M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.85M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.20M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.74M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.62M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.24M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.81M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.09M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.90M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.59M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.83M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.08M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.56M | – |
See a number that looks wrong?